Previous close | 206.35 |
Open | 206.41 |
Bid | 226.00 |
Ask | 232.60 |
Strike | 675.00 |
Expiry date | 2024-06-28 |
Day's range | 206.10 - 206.41 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Automated pumps are already used by about 40% of those with the autoimmune version of diabetes, known as Type-1.
Novo Nordisk (NVO) plans to invest $4.1 billion in order to expand its Clayton facility with a second manufacturing plant, boosting capacity for injectable treatments and creating 1,000 new jobs.
Assuming the rosier expectations will positively unfold, a reality check is done to compare the current valuation to informative financial ratios